Northside Hospital-Northside Hospital Oncology Network ( Site 0100) — Atlanta, Georgia

Northside Hospital-Northside Hospital Oncology Network ( Site 0100) is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Northside Hospital-Northside Hospital Oncology Network ( Site 0100) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital-Northside Hospital Oncology Network ( Site 0100)?

Northside Hospital-Northside Hospital Oncology Network ( Site 0100) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital-Northside Hospital Oncology Network ( Site 0100) conducted?

Northside Hospital-Northside Hospital Oncology Network ( Site 0100) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Is Northside Hospital-Northside Hospital Oncology Network ( Site 0100) accredited by Crixeo Health?

Northside Hospital-Northside Hospital Oncology Network ( Site 0100) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital-Northside Hospital Oncology Network ( Site 0100)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.